Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use.

Autor: Fung, Simon1 dtp@adis.com, Blair, Hannah A.1
Zdroj: Drugs & Therapy Perspectives. Nov2024, Vol. 40 Issue 11, p433-443. 11p.
Databáze: Academic Search Ultimate